From the UK, a continuation decision for Palantir, which produces technology for Israel
Original headlineİsrail'e teknoloji üreten Palantir'e İngiltere'den devam kararı
Not investment advice. Muhabbit scores how much a story may matter, not which way to trade.
The UK government has extended Palantir’s NHS data-analytics contract, worth £330 million, through 2029, keeping the US firm’s AI-powered tools in place despite controversy over its technology supplies to Israel. The decision secures one of Palantir’s largest public-sector deals outside the US and reinforces its role in Britain’s health-data infrastructure. The contract covers analytics work for the National Health Service, where Palantir has faced scrutiny from privacy advocates and lawmakers over how patient data is handled. The extension also comes as the company balances growing government demand for AI surveillance and data tools against political sensitivities tied to its Israel work. Next, watch for scrutiny from UK regulators and parliamentary committees over data governance, and for any signal on whether the NHS relationship expands further.
Muhabbit's AI wrote this summary in its own words from Ekonomim's report and translated it from Turkish. It can get details wrong, so check the source.
Named in this story
Palantir (PLTR), NHS, UK government, Israel
A linked name opens that asset's sentiment page.